IL-2 therapy preferentially expands adoptively transferred donor-specific Tregs improving skin allograft survival. (2019)
Attributed to:
USE OF LOW-DOSE IL-2 TO EXPAND ENDOGENOUS REGULATORY T CELLS AND ACHIEVE TRANSPLANTATION TOLERANCE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ajt.15306
PubMed Identifier: 30748096
Publication URI: http://europepmc.org/abstract/MED/30748096
Type: Journal Article/Review
Volume: 19
Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Issue: 7
ISSN: 1600-6135